Publications by authors named "Clare Morey"
Objective: To evaluate the efficacy of a novel intervention aimed at enhancing self-advocacy in individuals living with traumatic brain injury (TBI).
Setting: Community.
Participants: Sixty-seven (35 allocated to treatment, 32 to control) community-dwelling adults 9 months or more post-TBI (mean of 8.
Objective: To evaluate the efficacy of a novel intervention facilitating volunteer activity to improve well-being in individuals with traumatic brain injury (TBI).
Design: Randomized two-arm controlled trial, with a wait-list control condition (ClinicalTrials.gov NCT#01728350).
Objective: To evaluate the effectiveness of a replicable group treatment program for improving social competence after traumatic brain injury (TBI).
Design: Multicenter randomized controlled trial comparing 2 methods of conducting a social competency skills program, an interactive group format versus a classroom lecture.
Setting: Community and veteran rehabilitation centers.
Background: Well-being and quality of life issues remain a long-term problem for many individuals with traumatic brain injury (TBI). Meaningful activity is key to developing life satisfaction and a sense of contribution to society, yet individuals with TBI are often unable to return to competitive employment.
Objective: To describe the self-reported psychological well-being of a cohort of unemployed individuals living in the community at least 1 year post TBI with low life satisfaction.
Objectives: To describe the prevalence of cannabis use in an adult sample with spinal cord injury (SCI) or traumatic brain injury (TBI) in Colorado, and to describe the self-reported reasons and side effects of cannabis use in this sample.
Design: Mixed-methods observational study, using focus group data and telephone survey.
Setting: Community.
Objective: To investigate the feasibility of a self-advocacy intervention for individuals with acquired brain injury (ABI).
Design: Two-arm, parallel-design, randomized feasibility study.
Methods: Twelve participants, 1-year or more post-ABI (TBI and cerebral vascular accident (CVA)), were randomized into treatment/control groups.
Purpose/objective: The purpose of this study was to evaluate the psychometric properties of 2 novel measures assessing personal advocacy, self-efficacy and personal advocacy activities in individuals with acquired brain injury (ABI).
Design: This was an instrument development study using (a) expert panel review with a content validity index, (b) consumer survey, and (c) Rasch analysis. Participants were adults (N = 162) with ABI recruited through a community survey.
Objective: To determine if atomoxetine would improve attention impairment following traumatic brain injury (TBI).
Setting: Outpatients from a free-standing, private, not-for-profit rehabilitation hospital.
Population: Fifty-five adult participants with a history of a single moderate-to-severe TBI, who were at least 1 year from injury and with self-reported complaints of attention difficulties.
Objectives: To assess the efficacy of a standardized 12-week health and wellness group intervention for those with moderate to severe traumatic brain injury (TBI).
Study Design: Randomized controlled trial.
Participants: Seventy-four individuals with moderate to severe TBI recruited from the outpatient program at a rehabilitation hospital, a Veterans Affairs Medical Center, and the community.
Objective: To describe health and wellness characteristics of persons with TBI living in the community, compare to other disability populations and evaluate the associations between health-related constructs.
Design: Observational.
Setting: Outpatient rehabilitation hospital and a Veterans Affairs Medical Centre.
Objectives: To evaluate the feasibility of improving impaired social communication skills in persons with traumatic brain injury (TBI) and concomitant neurological or psychiatric conditions, using an intervention with evidence of efficacy in a TBI cohort without such complications.
Research Design: Cohort study with pre-post intervention and follow-up assessments.
Methods: Thirty individuals with TBI ≥ 1 year post-injury and identified social communication problems participated in a group intervention to improve social communication skills.
Objectives: To determine the impact of traumatic brain injury (TBI) on female menstrual and reproductive functioning and to examine the relationships between severity of injury, duration of amenorrhea, and TBI outcomes.
Design: Retrospective cohort survey.
Setting: Telephone interview.
Background: This study examines the efficacy of modafinil in treating fatigue and excessive daytime sleepiness in individuals with traumatic brain injury (TBI).
Methods: A single-center, double-blind, placebo-controlled cross-over trial, where 53 participants with TBI were randomly assigned to receive up to 400 mg of modafinil, or equal number of inactive placebo tablets. Main eligibility criteria were being at least 1 year post-TBI severe enough to require inpatient rehabilitation.
Objective: To evaluate the efficacy of a replicable group treatment program to improve social communication skills after traumatic brain injury (TBI).
Design: Randomized treatment and deferred treatment controlled trial, with follow-up at 3, 6, and 9 months post-treatment.
Setting: Community.
Objective: To describe social communication skills problems identified by individuals with traumatic brain injury (TBI) compared to significant other (SO) and clinician ratings; and associations between these skills and participation outcome measures.
Design: Cohort study.
Methods: Sixty individuals with TBI > or = 1 year post-injury were administered measures of social communication, societal participation, social integration and life satisfaction.
Primary Objective: To investigate the effectiveness of donepezil hydrochloride (Aricept) in treating persistent memory deficits in people with traumatic brain injury.
Research Design: Single subject ABAC design was used so that each participant could serve as their own control.
Methods And Procedures: Seven TBI survivors with persistent memory dysfunction, at least 1.